Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07812571) titled 'Tenofovir Exposures in Advanced Kidney Disease Study' on Sept. 1.
Study Type: Observational
Primary Sponsor: King's College Hospital NHS Trust
Condition:
Tenofovir
Tenofovir Alafenamide Fumarate
Chronic Kidney Diease
Kidney Failure
Pharmacokinetics
Intervention:
Diagnostic Test: Plasma sampling for tenofovir and emtricitabine
Recruitment Status: Not recruiting
Date of First Enrollment: November 1, 2026
Target Sample Size: 50
Countries of Recruitment:
United Kingdom
To know more, visit https://clinicaltrials.gov/study/NCT07812571
Disclaimer: Curated by HT Syndication....